PAVmed Inc. Series Z Warrant
PAVMZ
PAVMZ was delisted on the 30th of April, 2025.
7 hedge funds and large institutions have $1.14M invested in PAVmed Inc. Series Z Warrant in 2019 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and closing their positions.
17% more funds holding
Funds holding: 6 → 7 (+1)
7% less capital invested
Capital invested by funds: $1.22M → $1.14M (-$82K)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LCS
Levin Capital Strategies
New York
|
+$8.96K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$63 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$255K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$27.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$4.42K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $836K | -$255K | -811,910 | -27% |
|
|
LCS
2
Levin Capital Strategies
New York
| $264K | +$8.96K | +28,533 | +4% |
|
|
MRCM
3
M&R Capital Management
Summit,
New Jersey
| $32K | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $9K | -$27.1K | -86,353 | -79% |
|
|
5
UBS Group
Zurich,
Switzerland
| – | -$4.42K | -14,097 | -99% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$63 | +200 | New |
|
PAVMZ Hedge Fund Activity: Q4 2019 in Review
7 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in PAVmed Inc. Series Z Warrant (PAVMZ) for Q4 2019, worth a combined $1.14M — down 6.7% from $1.22M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new PAVMZ positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 3 trimmed.
The largest buyer was Levin Capital Strategies, adding an estimated $8.96K. The largest seller was Sabby Management, cutting an estimated $255K.
- 7 institutional investors held PAVmed Inc. Series Z Warrant (PAVMZ) as of Q4 2019, up from 6 in Q3 2019.
- Funds reported $1.14M of PAVmed Inc. Series Z Warrant stock for Q4 2019, down 6.7% quarter-over-quarter.
- 1 fund opened new PAVmed Inc. Series Z Warrant positions in Q4 2019 and 0 closed out, a net change of +1 holder.
- The largest PAVmed Inc. Series Z Warrant buyer in Q4 2019 was Levin Capital Strategies, an estimated $8.96K added.
- The largest PAVmed Inc. Series Z Warrant seller in Q4 2019 was Sabby Management, an estimated $255K sold.
Based on aggregated 13F filings for Q4 2019.